BBI Life Sciences Corp ($1035) - buy or sell? Stock discussion, ideas, forum

BBI Life Sciences Corp

BBI Life Sciences Corporation operates in the life sciences research products and services industry.

Industry: Healthcare-Products

Ticker	Exchange	ISIN	Name
$1035	HKEx Main Board	KYG1089Y1180	Code: 1035

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1035 stock

Share your investment idea or question on BBI Life Sciences Corp stock:

Latest twits on BBI Life Sciences Corp (1035)

No twits yet. Be the first to post!

Have a question about 1035? Ask and other investors will be eager to help you.

Have an idea about 1035? Share it with other investors.

BBI Life Sciences Corp news

24/03/2017 BBI Life Sciences Corp EBITDA Margin dropped on 25.5 pp from 25.5% to in 2016

BBI Life Sciences Corp stock price chart

BBI Life Sciences Corp financials

mln. CNY	FY2011	FY2012	FY2013

Revenue	160.1	186.4	220.0
EBITDA	48.349	47.962	57.202
Net income	33.009	33.431	40.249
CAPEX	49.793	43.981	14.845
Debt	0.051	11.251	0.000
Cash	34.006	18.185	47.420

BBI Life Sciences Corp news

24/03/2017 BBI Life Sciences Corp EBITDA Margin dropped on 25.5 pp from 25.5% to in 2016

About BBI Life Sciences Corp

BBI Life Sciences Corporation operates in the life sciences research products and services industry. The Company's products and services are applied to DNA synthesis, genetic engineering, life sciences research consumables, and protein and antibody related products and services. BBI serves universities, research institutions, hospitals, pharmaceutical companies, and the government.